Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 817,609 | 801,713 | 866,562 | -363,295 | -297,409 |
| Depreciation Amortization | 13,847 | 8,635 | 5,207 | 223,880 | 59,843 |
| Income taxes - deferred | -4 | N/A | 2 | -55,912 | -2 |
| Accounts receivable | -32,365 | -25,891 | -47,792 | 1,732 | -39,029 |
| Other Working Capital | -143,677 | -58,801 | -42,081 | 100,743 | 64,164 |
| Other Operating Activity | 90,059 | 86,114 | 88,205 | -14,836 | 134,749 |
| Operating Cash Flow | $745,469 | $811,770 | $870,103 | $-107,688 | $-77,684 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -633,341 | -599,913 | -181,898 | -248 | -193,834 |
| PPE Investments | -6,416 | -2,971 | -1,654 | 21,554 | 25,321 |
| Net Acquisitions | N/A | -3,485 | N/A | N/A | N/A |
| Purchase Of Investment | N/A | N/A | N/A | -59,377 | 10,000 |
| Purchase Sale Intangibles | -256,235 | N/A | -808 | -67,747 | -65,017 |
| Other Investing Activity | -256,235 | 0 | -808 | 82,253 | -65,017 |
| Investing Cash Flow | $-895,992 | $-606,369 | $-184,360 | $44,182 | $-223,530 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 241,792 |
| Debt Repayment | -7,952 | N/A | N/A | -1,490 | -19,690 |
| Common Stock Issued | 36,542 | 19,712 | 15,751 | 33,764 | 7,293 |
| Other Financing Activity | 0 | -6,341 | -6,341 | 223,592 | 0 |
| Financing Cash Flow | $28,590 | $13,371 | $9,410 | $255,866 | $229,395 |
| Exchange Rate Effect | 12,917 | 18,981 | 5,393 | -7,328 | 1,325 |
| Beginning Cash Position | 795,316 | 795,316 | 795,316 | 610,284 | 610,284 |
| End Cash Position | 686,300 | 1,033,069 | 1,495,862 | 795,316 | 539,790 |
| Net Cash Flow | $-109,016 | $237,753 | $700,546 | $185,032 | $-70,494 |
| Free Cash Flow | |||||
| Operating Cash Flow | 745,469 | 811,770 | 870,103 | -107,688 | -77,684 |
| Capital Expenditure | -6,486 | -3,041 | -1,724 | -6,502 | -2,735 |
| Free Cash Flow | 738,983 | 808,729 | 868,379 | -114,190 | -80,419 |